stockrowCollegium Pharmaceutical, Inc. (COLL) vs Harrow, Inc. (HROW)
- Collegium Pharmaceutical, Inc. COLL 25.07 +5.91%
- Harrow, Inc. HROW 26.05 −9.39%
Collegium Pharmaceutical, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Harrow, Inc. is the larger, with a market value of $976.2M against $819.1M — 1.2× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 20.5×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 7.68%. Collegium Pharmaceutical, Inc. has the higher net margin (4.68% vs −13.5%) and the higher return on invested capital (5.63% vs −0.77%). Across the 20 metrics below, Collegium Pharmaceutical, Inc. leads on 14 and Harrow, Inc. on 6.
Valuation
Profitability
| Metric | COLL | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 59.05% | 73.28% | 53.51% |
| Operating margin | 15.22% | (1.00%) | 0.00% |
| Net margin | 4.68% | (13.51%) | (2.45%) |
| Free cash flow margin | 41.25% | (4.75%) | 0.00% |
| Return on equity | 13.36% | (116.07%) | (0.80%) |
| Return on assets | 2.06% | (9.77%) | (1.67%) |
| Return on invested capital | 5.63% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack